DCD-13199-75234
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 372 / TN
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Registered in v-safe
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal menstrual clots, Heavy menstrual bleeding, Menstrual disorder — Feeling: GoodFree text: Started menstruating today, 4 days early, heavy flow with small clots. This is unusual for my cycle; I am consistent with timing and flow. I am not on birth control or any medication. Stress levels have not fluctuated and do not appear to be a contributing factor to early start.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal menstrual clots, Heavy menstrual bleeding, Menstruation irregular — Feeling: GoodFree text: Continued heavy, early menstruation with numerous clots.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Heavy menstrual bleeding, Menstrual clots, Polymenorrhoea — Feeling: GoodFree text: Im early menstruating- still heavy and with clotting. Aside from early start date, the flow type is also atypical.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — day 7, dose 2MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Im continuing to heavily menstruate. This cycle is earlier, heavier and lasting longer than usualMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-07-24
- 2021-10-23
-
2022-04-24
Survey response — 12 months, dose 2MedDRA: Dysgeusia, Fatigue, Pain, Parosmia, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Self-medication — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I developed a fever 4/15, congestion, overall tiredness & body aches. Treated somewhat successfully w Tylenol & sambucol. Fever subsided approx 4/20, still tired. Taste & smell became distorted & took 2 covid tests 4/22. Positive results each time.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Started menstruating today, 4 days early, heavy flow with small clots. This is unusual for my cycle; I am consistent with timing and flow. I am not on birth control or any medication. Stress levels have not fluctuated and do not appear to be a contributing factor to early start.
Systemic reaction (other): Continued heavy, early menstruation with numerous clots.
Systemic reaction (other): Im early menstruating- still heavy and with clotting. Aside from early start date, the flow type is also atypical.
Release 8 — day 7, dose 2
Systemic reaction (other): Im continuing to heavily menstruate. This cycle is earlier, heavier and lasting longer than usual
Release 11 — 12 months, dose 2
Symptoms: I developed a fever 4/15, congestion, overall tiredness & body aches. Treated somewhat successfully w Tylenol & sambucol. Fever subsided approx 4/20, still tired. Taste & smell became distorted & took 2 covid tests 4/22. Positive results each time. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysgeusia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SRO | Abnormal menstrual clots | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Menstrual clots | ✓ | ✓ | ✓ |
| SRO | Menstrual disorder | ✓ | ✓ | ✓ |
| SRO | Menstruation irregular | ✓ | ✓ | ✓ |
| SRO | Polymenorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release